Management Team 2019-06-26T15:13:41+00:00

Management Team

Anders Rylander (1970)CEO since 2010
Anders Rylander has an MSc in Mechanical Engineering with specialties in Industrial Economics and Management from the Swedish Royal Institute of Technology. He has been a management consultant for more than 15 years, at companies such as Accenture and Andersen Consulting. Anders co-founded Axholmen, a management consulting firm that focuses on improving the operational efficiency of large corporations in the Nordic market. He also founded Arinvest, a private equity investment firm investing in the clean-tech and life science business areas.

Holdings: 3 575 640 A-shares, 368 956 B-shares

Cecilia Driving (1971)CFO since 2016
Cecilia holds a LLM and BSc in Business Administration from Stockholm University. She has held several CFO positions in life-science, private equity, research and telecom companies. She also serves as Chairman of Adom AB.

Holdings: 10 000 B-shares, 20 000 warrants 2017/2020 (TO2), 20 000 warrants 2018/2021 (TO3)

Karin Mattsson, Ph.D. (1970)R&D Director since 2017
Karin received a Master’s degree in molecular biology from Uppsala University and a PhD in cell and tumor biology from the Karolinska Institute. She has more than 20 years’ experience of working within academic research and the biomedical industry. She has held various technical and managerial positions within in research and development and has significant experience of in-vitro diagnostic assay development. Previously, Karin served as Product Development Manager and Deputy Head of R&D at Olerup SSP, a company that develops, manufactures and markets molecular diagnostic products.

Holdings: 1 000 B-shares, 20 000 warrants 2017/2020 (TO2), 20 000 warrants 2018/2021 (TO3)

Mattias Bergqvist (1970)Clinical Development Director since 2011
Mattias holds a BSc in Marketing and has worked for Biovica since 2012. During his more than 20 years of experience in the pharmaceutical and biotechnology industry, he has launched oncology drugs with tailored diagnostics and co-authored publications with results from oncology benchmark trials. He previously worked as Nordic TA Director in Specialty Care and Oncology at AstraZeneca and in the Global Marketing Division at AstraZeneca UK.

Holdings: 106 560 B-shares, 20 000 warrants 2017/2020 (TO2)

Adam Germunder (1984)Operations Director since 2017
Adam holds a BSc in Mechanical Engineering from Uppsala University.
Adam has experience from production management and process development in the life science business. Before joining Biovica Adam worked as a production manager at Fiomi Diagnostics AB and as teamleader at Fresenius Kabi.

Holdings: 4 600 B-shares, 20 000 warrants 2018/2021 (TO3)

Pontus Nobréus (1964)Business Development Director since 2018
Pontus has had commercial roles for 20 years, especially in diagnostics and laboratory industries. He has long international experience and has been stationed in the United States and South Africa. Pontus has, among other things, held regional sales responsibility for HemoCue and comes from a service as Global Export Manager at Euro Diagnostica.

Holdings: 6 000 B-shares, 20 000 warrants 2018/2021 (TO3)

Wing Cheng, Ph.D. (1974)Market Access and Quality Assurance Director since 2018
Wing Cheng received a Ph.D. in Clinical Immunology and a Master of Science in Molecular Biotechnology from Uppsala University. Wing has held leading positions within the Regulatory and Reimbursement area from Competent Authorities e.g The Dental and Pharmaceutical Benefits Agency (TLV), the Medical Products Agency (MPA), European Medicine Agency (EMA) and the European Commission. Previously he served as Manager Clinical Utility at Thermo Fisher Scientific.

Holdings: 3 700 B-shares, 20 000 warrants 2018/2021 (TO3)